Dihydroartemisinin Regulates the Th/Treg Balance by Inducing Activated CD4+ T cell Apoptosis via Heme Oxygenase-1 Induction in Mouse Models of Inflammatory Bowel Disease

@article{Yan2019DihydroartemisininRT,
  title={Dihydroartemisinin Regulates the Th/Treg Balance by Inducing Activated CD4+ T cell Apoptosis via Heme Oxygenase-1 Induction in Mouse Models of Inflammatory Bowel Disease},
  author={Sirui Yan and Ya Wang and Yu Jie Li and Wei-yan Cai and Xiao-gang Weng and Qi Li and Ying Chen and Qing Yang and Xiao Xin Zhu},
  journal={Molecules},
  year={2019},
  volume={24}
}
Dihydroartemisinin (DHA) is a derivative of the herb Artemisia annua L. that has prominent immunomodulatory activity; however, its underlying mechanism remains elusive. Inflammatory bowel disease (IBD) is an idiopathic inflammatory condition characterized as an autoimmune disorder that includes dysfunctions in the T helper (Th)/T regulatory cell (Treg) balance, which normally plays pivotal roles in immune homeostasis. The aim of this study was to explore the potential of DHA to ameliorate IBD… 

Figures and Tables from this paper

Dihydroartemisinin attenuated the symptoms of mice model of systemic lupus erythematosus by restoring the Treg/Th17 balance
TLDR
It was shown that DHA alone or in combination with prednisone treatment significantly alleviated the manifestations of pristane‐induced SLE mice, suppressed inflammation and restored the Treg/Th17 balance.
Dihydroartemisinin Alleviates Imiquimod-Induced Psoriasis-like Skin Lesion in Mice Involving Modulation of IL-23/Th17 Axis
TLDR
DHA inhibits the progression of psoriasis by regulating IL-23/Th17 axis and is expected to be an effective drug for the treatment of psoriatic condition.
Dihydroartemisinin Promoted Bone Marrow Mesenchymal Stem Cell Homing and Suppressed Inflammation and Oxidative Stress against Prostate Injury in Chronic Bacterial Prostatitis Mice Model
TLDR
Evidence is provided that DHA effectively eliminated inflammatory and oxidative stress against prostate injury, and this effect involved the TGF-β/Smad signaling pathway in CBP.
Dihydroartemisinin ameliorates psoriatic skin inflammation and its relapse by diminishing CD8+ T-cell memory in wild-type and humanized mice
TLDR
The first evidence that DHA is advantageous over MTX in preventing psoriasis relapse by reducing memory CD8+ T-cells is provided.
Heme-Oxygenase-1 Attenuates Oxidative Functions of Antigen Presenting Cells and Promotes Regulatory T Cell Differentiation during Fasciola hepatica Infection
TLDR
It is shown that F. hepatica-infected mice upregulate HO-1 on peritoneal antigen-presenting cells (APC), which produce decreased levels of both reactive oxygen and nitrogen species (ROS/RNS).
Butyric Acid Protects Against Renal Ischemia–Reperfusion Injury by Adjusting the Treg/Th17 Balance via HO-1/p-STAT3 Signaling
TLDR
It is confirmed that Butyric acid promotes the differentiation of Th17 cells into Treg cells by regulating the pathway and reduces renal IRI.
Therapeutic effects of dihydroartemisinin in multiple stages of colitis-associated colorectal cancer
TLDR
It is indicated that DHA could be a potent agent in managing the initiation and development of CAC without obvious side effects, warranting further clinical translation of DHA for CAC treatment.
...
1
2
...

References

SHOWING 1-10 OF 53 REFERENCES
Dihydroartemisinin Ameliorates Inflammatory Disease by Its Reciprocal Effects on Th and Regulatory T Cell Function via Modulating the Mammalian Target of Rapamycin Pathway
TLDR
A novel immune regulatory function of DHA is revealed in reciprocally regulating Th and Treg cell generation through the modulating mTOR pathway, which addresses how DHA regulates immune function and suggests a new type of drug for treating diseases in which mTOR activity is to be tempered.
BLT1 in dendritic cells promotes Th1/Th17 differentiation and its deficiency ameliorates TNBS-induced colitis
TLDR
It is reported that BLT1 regulates trinitrobenzene sulfonic acid (TNBS)-induced colitis, which reflects CD4+ T-cell-dependent adaptive immune mechanisms of IBD, and further supports BLT 1 as a potential drug target for adaptive immunity-mediated IBD.
Immunomodulatory and anti-inflammatory properties of artesunate in experimental colitis.
TLDR
The data suggest a novel clinical application of artesunate as a potential therapy for Crohn's disease and in vitro and in vivo treatment significantly inhibited TNF-α production by LPS-activated macrophages.
Galectin-1 suppresses experimental colitis in mice.
Artemisinin analogue SM934 ameliorates DSS-induced mouse ulcerative colitis via suppressing neutrophils and macrophages
TLDR
The results reveal the protective effects of SM934 on DSS-induced colitis can be attributed to its suppressing effects on neutrophils and macrophages and its inhibitory role in the NF-κB signaling, suggests thatSM934 might be a potential effective drug for ulcerative colitis.
The Treg/Th17 Axis: A Dynamic Balance Regulated by the Gut Microbiome
TLDR
Dysbiosis of the gut microbiome may not solely represent a consequence of gut inflammation, but rather shape the Treg/Th17 commitment and influence susceptibility to inflammatory bowel disease.
Pharmacological application of carbon monoxide ameliorates islet-directed autoimmunity in mice via anti-inflammatory and anti-apoptotic effects
TLDR
The ability of CORM-A1 to protect mice from developing type 1 diabetes provides a valuable proof of concept for the potential exploitation of controlled CO delivery in clinical settings for the treatment of autoimmune diabetes.
DC32, a Dihydroartemisinin Derivative, Ameliorates Collagen-Induced Arthritis Through an Nrf2-p62-Keap1 Feedback Loop
TLDR
It is demonstrated that DC32 significantly suppressed rheumatoid arthritis (RA) via the Nrf2-p62-Keap1 feedback loop by increasing the mRNA and protein levels of NRF2 and inducing p62 expression.
JNK Pathway-Associated Phosphatase/DUSP22 Suppresses CD4+ T-Cell Activation and Th1/Th17-Cell Differentiation and Negatively Correlates with Clinical Activity in Inflammatory Bowel Disease
TLDR
The data indicated that the decreased expression of JKAP in intestinal mucosa contributed to the pathogenesis of IBD, through facilitating CD4+ T-cell activation, proliferation, and Th1/Th17-cell differentiation.
SM934, a water-soluble derivative of arteminisin, exerts immunosuppressive functions in vitro and in vivo.
...
1
2
3
4
5
...